摘要
<正>幽门螺杆菌(Hp)是胃炎、消化性溃疡和胃腺癌致病因素。除了胃部疾病,Hp也与各种非胃肠相关疾病,如冠状动脉动脉疾病、自身免疫病和恶性贫血有关~([1])。最近有研究证实,Hp是特发性血小板减少性紫癜(ITP)的致病因素。目前主要采取类固醇、球蛋白、抗RhD、脾切除术、免疫抑制剂和其他疗法用于治疗ITP。在这些治疗方法中,类固醇治疗是最有效的;然而,如果停药,大多数患者可能复发。当使用其他治疗方法时,64%ITP患者表现出
引文
[1]涂莎,阳惠湘.幽门螺杆菌感染治疗的进展[J].中南大学学报(医学版),2014,39(9):981-988.
[2] Sato R,Murakami K,Watanabe K,et al. Development of corpus atrophic gastritis may be associated with Helicobacter pylorirelated idiopathic thrombocytopenic purpura[J]. J Gastroenterol,2011,46(8):991-997.
[3] Kohda K,Kuga T,Kogawa K,et al. Effect of Helicobacter pylori eradication on platelet recovery in Japanese patients with chronic idiopathic thrombocytopenic purpura and secondary autoimmune thrombocytopenic purpura[J]. Br J Haematol,2015,118(2):584-588.
[4] Sato R,Murakami K,Watanabe K,et al. Development of corpus atrophic gastritis may be associated with Helicobacter pylorirelated idiopathic thrombocytopenic purpura[J]. J Gastroenterol,2011,46(8):991-997.
[5] Arnold DM,Bernotas A,Nazi I,et al. Platelet count response to H. pylori treatment in patients with immune thrombocytopenic purpura with and without H. pylori infection:a systematic review[J]. Haematologica,2009,94(6):850-856.
[6]田艳琼.根除幽门螺杆菌对成人特发性血小板减少性紫癜患者疗效的影响[J].中国当代医药,2012,19(5):50-51.
[7] Fujimura K,Kuwana M,Kurata Y,et al. Is eradication therapy useful as the first line of treatment in helicobacter pylori-positive idiopathic thrombocytopenic purpura? Analysis of 207eradicated chronic ITP cases in Japan[J]. Int J Hematology,2005,81(2):162-168.